New Alzheimer’s drug approved in UK, but government won’t pay for it
The drug is the second Alzheimer’s medicine to receive a lukewarm reception from the UK government in recent months.
The drug is the second Alzheimer’s medicine to receive a lukewarm reception from the UK government in recent months.
What's Your Reaction?
